Hemsyl 500mg Tablet contains Ethamsylate, a hemostatic agent used to reduce bleeding by promoting capillary resistance and restoring platelet function. It is primarily indicated for the prevention and treatment of capillary bleeding in various clinical conditions such as menorrhagia, postoperative bleeding, and hemorrhagic disorders associated with platelet dysfunction. Ethamsylate acts by enhancing platelet adhesiveness and improving capillary wall stability, thereby reducing bleeding time without affecting coagulation parameters significantly. This makes it particularly useful in managing bleeding where coagulation tests remain normal. Hemsyl 500mg is administered orally, with dosage and duration tailored according to the clinical condition and physician’s discretion. It is generally well tolerated, with minimal adverse effects; however, hypersensitivity reactions and gastrointestinal disturbances may occur in rare cases. Caution is advised in patients with known hypersensitivity to Ethamsylate or excipients, and it should be used under medical supervision, especially in individuals with severe renal or hepatic impairment. Hemsyl 500mg Tablet is an effective adjunct in controlling bleeding episodes and improving hemostasis, contributing to better clinical outcomes in patients with bleeding tendencies.